antigen bias t cell cross-priming 
activated cd8+ t cells detect virally infected cells tumor cells recognition major histocompatibility complex class i-bound peptides derived degraded endogenously produced proteins contrast cd8+ t cell activation often occurs interaction specialized antigen-presenting cells displaying peptides acquired exogenous cellular source process termed cross-priming observed marked inefficiency exogenous presentation epitopes derived signal sequences mouse models data indicate certain virus tumor-associated antigens may detected cd8+ t cells impaired cross-priming differences ability cross-present antigens form important considerations vaccine design 
